A National Cooperative Growth Study of Protropin

Nearly 2000 hGH deficient patients have been enrolled in a study of Protropin and followed up for up to 1 year. This has provided valuable information on the character of this population and its response to therapy. Overall there was a predominance of males, with a disproportionate number of short mothers. The mean Protropin dose was 0.07 mg/kg, given three times/week. There was a significant dose-response relationship up to 0.125 mg/kg three times/week.